BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8900089)

  • 21. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
    Puel A; Ziegler SF; Buckley RH; Leonard WJ
    Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells.
    DiSanto JP; Rieux-Laucat F; Dautry-Varsat A; Fischer A; de Saint Basile G
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9466-70. PubMed ID: 7937790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: molecular and cellular characterization.
    Mella P; Imberti L; Brugnoni D; Pirovano S; Candotti F; Mazzolari E; Bettinardi A; Fiorini M; De Mattia D; Martire B; Plebani A; Notarangelo LD; Giliani S
    Clin Immunol; 2000 Apr; 95(1 Pt 1):39-50. PubMed ID: 10794431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
    Wengler GS; Allen RC; Parolini O; Smith H; Conley ME
    J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical research. Gene therapy a suspect in leukemia-like disease.
    Marshall E
    Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
    [No Abstract]   [Full Text] [Related]  

  • 26. The molecular basis of X-linked agammaglobulinemia, hyper-IgM syndrome, and severe combined immunodeficiency in humans.
    Aruffo A; Hollenbaugh D; Wu LH; Ochs HD
    Curr Opin Hematol; 1994 Jan; 1(1):12-8. PubMed ID: 9371254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The signal transduction mechanism of IL-4 in X-linked severe combined immunodeficiency patients].
    Izuhara K
    Rinsho Ketsueki; 1997 Mar; 38(3):186-8. PubMed ID: 9095654
    [No Abstract]   [Full Text] [Related]  

  • 28. LMO2 and gene therapy for severe combined immunodeficiency.
    Fischer A; Abina SH; Thrasher A; von Kalle C; Cavazzana-Calvo M
    N Engl J Med; 2004 Jun; 350(24):2526-7; author reply 2526-7. PubMed ID: 15190153
    [No Abstract]   [Full Text] [Related]  

  • 29. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
    Carbonara A; Brusco A; Carbonara C
    Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intronic point mutation in the IL2RG gene causing X-linked severe combined immunodeficiency.
    Tassara C; Pepper AE; Puck JM
    Hum Mol Genet; 1995 Sep; 4(9):1693-5. PubMed ID: 8541866
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutations in the gene for the common gamma chain (gammac) in X-linked severe combined immunodeficiency.
    Fugmann SD; Müller S; Friedrich W; Bartram CR; Schwarz K
    Hum Genet; 1998 Dec; 103(6):730-1. PubMed ID: 9921912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.
    Leonard WJ
    Annu Rev Med; 1996; 47():229-39. PubMed ID: 8712778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CD3delta deficiency on maturation of alpha/beta and gamma/delta T-cell lineages in severe combined immunodeficiency.
    Dadi HK; Simon AJ; Roifman CM
    N Engl J Med; 2003 Nov; 349(19):1821-8. PubMed ID: 14602880
    [No Abstract]   [Full Text] [Related]  

  • 34. Three novel mutations in the interleukin-2 receptor gamma chain gene in four Japanese patients with X-linked severe combined immunodeficiency.
    Minegishi Y; Ishii N; Maeda H; Takagi S; Tsuchida M; Okawa H; Sugamura K; Yata J
    Hum Genet; 1995 Dec; 96(6):681-3. PubMed ID: 8522327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
    Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
    Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [X-linked severe combined immunodeficiency].
    Kumaki S
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):140-5. PubMed ID: 11963175
    [No Abstract]   [Full Text] [Related]  

  • 37. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
    Puck JM; Deschênes SM; Porter JC; Dutra AS; Brown CJ; Willard HF; Henthorn PS
    Hum Mol Genet; 1993 Aug; 2(8):1099-104. PubMed ID: 8401490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe combined immunodeficiency due to a defect in the tyrosine kinase ZAP-70.
    Elder ME
    Pediatr Res; 1996 May; 39(5):743-8. PubMed ID: 8726223
    [No Abstract]   [Full Text] [Related]  

  • 39. A single nucleotide insertion in the canine interleukin-2 receptor gamma chain results in X-linked severe combined immunodeficiency disease.
    Somberg RL; Pullen RP; Casal ML; Patterson DF; Felsburg PJ; Henthorn PS
    Vet Immunol Immunopathol; 1995 Aug; 47(3-4):203-13. PubMed ID: 8571541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemophagocytic lymphohistiocytosis in X-linked severe combined immunodeficiency.
    Grunebaum E; Zhang J; Dadi H; Roifman CM
    Br J Haematol; 2000 Mar; 108(4):834-7. PubMed ID: 10792291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.